Target intelligence / Profile preview

MicroRNA 4666a (MIR4666A)

Target
MIR4666A
Molecular classification
MicroRNA, Non-coding RNA, Regulatory RNA
01

Overview

MicroRNA 4666a (MIR4666A) is a member of the microRNA family, comprised of small, single-stranded non-coding RNA molecules that regulate gene expression by binding to complementary sequences within messenger RNAs, typically causing translational repression or target degradation. It is generated from a precursor hairpin structure processed by the enzymes Drosha and Dicer, subsequently being loaded onto the Argonaute-associated RNA-induced silencing complex (RISC) for gene silencing action. MicroRNAs have a wide range of regulatory functions in development, differentiation, and disease, but explicit biological roles and disease relevance for MIR4666A specifically remain uncharacterized in current peer-reviewed literature. If more detailed functions, disease roles, or drug interactions for MIR4666A become available in future curated databases or experimental studies, they would be included in structured data mapping for therapeutic development and clinical research. At present, MIR4666A is correctly named as a microRNA, but specific attributes (disease roles, drugs) remain uncharacterized.

Other names
microRNA 4666aMIR4666Ahsa-mir-4666ahsa-mir-4666MIR4666microRNA 4666
02

Mechanism of action

mRNA degradation Translational inhibition Epigenetic regulation (chromatin remodeling, DNA methylation)

03

Biological functions

Gene regulationmRNA destabilization and degradationInhibition of translation initiationRNA interference and silencingPossible chromatin modulation and transcriptional regulation
04

Disease associations

Other (The specific disease association for MIR4666A is not well-documented; other microRNAs have roles in cancer, cardiovascular disease, neurodegeneration, inflammation, and infection)
05

Safety considerations

Off-target effects (common to miRNA therapeutics)Delivery and stability issuesUnintended gene regulation
06

Interacting drugs

No drugs documented to specifically interact with microRNA 4666a; however, miRNA-targeting oligonucleotides and mimics/antagonists are in development for many microRNAs in general
07

Biomarkers

Circulating miRNA (general for miRNAs; specific biomarker role for MIR4666A not established)

Beyond the preview

Go deeper on MicroRNA 4666a (MIR4666A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 4666a (MIR4666A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call